Up with Endo, Down with Allergan…Sort Of

Downgrading a stock from a Top Pick to Outperform doesn’t seem like much of a shift, thus Allergan (AGN) is barely moving in per market action, falling just 0.2% to $316.80 at today’s opening bell. In a report issued Friday, RBC Capital analyst Randall Stanicky downgraded the drug maker from Top Pick to Outperform, while [...]